**Background**
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and the accumulation of amyloid-beta plaques and tau tangles. Oxidative stress is a hallmark of AD pathogenesis, where the overproduction of reactive oxygen species (ROS) leads to cellular damage and neuronal death. The Nrf-2/HO-1 signaling pathway serves as a critical endogenous defense mechanism against oxidative stress, regulating the expression of antioxidant enzymes to maintain cellular homeostasis. Enhancing this pathway presents a promising therapeutic strategy for mitigating the progression of AD. In this context, we will introduce a pyridine derivative with potent antioxidant properties – Pyridoxine.
**Definition**
Pyridoxine (also known as Pyridoxol or Vitamin B6) is a pyridine alkaloid and human endogenous metabolite with the Pyridoxine Formula C8H12ClNO3 and a molecular weight of 205.64.
**In Vitro Studies**
According to the Pyridoxine description, this compound exerts significant protective effects in cell models of Alzheimer’s disease. Pyridoxine in vitro studies demonstrate that the compound possesses a strong protective potential against AD by attenuating ROS levels. Mechanistically, Pyridoxine biological activity is mediated through the Nrf-2/HO-1 pathway; it decreases the expressions of cytoplasmic Nrf2 and upregulates the expression of whole-cell heme oxygenase-1 (HO-1). These effects collectively reduce oxidative damage and enhance cellular survival in AD-related cell models. In conclusion, Pyridoxine is an antioxidant agent that protects against Alzheimer’s disease via the activation of the Nrf-2/HO-1 pathway.
Keywords
Pyridoxine, 58-56-0, Vitamin B6, Vitamin B 6, Vitamin B-6, Endogenous Metabolite, Keap1-Nrf2, Inhibitor, inhibitor, inhibit
References